isolates of extended-spectrum-beta-lactamase-producing Shigella sonnei. 
Cystic fibrosis (CF) is an autosomal recessive disease, characterised by defective chloride ion channels that result in multi-organ dysfunction, most notably affecting the respiratory tract. The alteration in the pulmonary environment is associated with increased susceptibility to bacterial infection. Recent advances in bacterial taxonomy and improved microbial identification systems have led to an increasing recognition of the diversity of bacterial species involved in CF lung infection. Many such species are opportunistic human pathogens, some of which are rarely found in other human infections [1] . Processing of CF respiratory cultures therefore employs selective media and focuses on detection of uncommon human pathogens. In recent years, the use of molecular methods (e.g., species-specific PCRs and assays based on identifying restriction fragment length polymorphisms) has complemented the diagnostic capacity of routine phenotypic analyses. The present study describes the use of molecular methods to identify Bordetella spp. in respiratory tract cultures from 43 patients with CF.
The supplemented with agar 1.6% w ⁄ v, and were incubated at 32°C for 24-48 h. DNA was prepared from bacterial cultures as described previously [2] . A PCR targeting the 16S rDNA of A. xylosoxidans was performed as described previously [3] . Bacterial genotyping was performed using rep-PCR with the BOX A1R primer (BOX-PCR) as described previously [4] , with cluster analyses performed by the unweighted pair-group method with arithmetic averages (UPGMA). 16S rDNA PCR amplification, sequencing and editing were performed as described previously [2] . Isolates were identified to the genus level if their edited and assembled 16S rDNA sequence identity compared with genera identified in the GenBank database was >95%; isolates were tentatively identified to the species level if the sequence identity was ‡99%. All 16S rDNA sequences determined in this study were deposited in GenBank under accession numbers EU082134-EU082176.
Only 11 (25%) of the 43 CF sputum culture isolates were identified correctly as Bordetella spp. by the referring laboratory, with the remainder being identified as Achromobacter spp. (n = 11), Burkholderia spp. (n = 2), or Pseudomonas spp. (n = 1), or as 'non-lactose-fermenting Gram-negative rod' or 'unidentified' (n = 18). A variety of commercial phenotypic test systems were used by the referring laboratories ( Table 1) .
The 43 isolates were analysed at the BcRLR by using a range of species-specific 16S rDNA PCR assays for CF-related bacterial species, including species of Pseudomonas, Stenotrophomonas, Burkholderia, Ralstonia, Pandoraea and Achromobacter [2, 3, [5] [6] [7] [8] [9] [10] [11] . All PCR assays were negative, except that 33 (77%) of the 43 isolates were positive according to a PCR assay designed to be specific for A. xylosoxidans [3] . However, cluster analysis of DNA profiles generated by BOX-PCR placed these 33 isolates (as well as the remaining ten isolates) in a cluster distinct from that formed by all other Achromobacter strains (including reference strains) in the BcRLR's collection (results not shown). 16S rDNA sequence analysis of the 43 isolates revealed that 23 were B. bronchiseptica ⁄ parapertussis, five were B. hinzii, four were Bordetella petrii, three were B. avium, and eight were unidentified Bordetella spp.
Although Bordetella spp. are not normally considered when evaluating CF sputum cultures, occasional case reports have described the recovery of some species, including B. hinzii [12, 13] , B. bronchiseptica [14, 15] and B. petrii [16] , from individual CF patients. To our knowledge, B. avium has not been identified previously in CF sputum cultures.
The frequency with which these species are involved in pulmonary infection in CF patients is unclear. During the 6-year period of this study, sputum isolates were analysed from 874 CF patients (receiving care in 183 treatment centres), with Bordetella strains isolated from 43 (5%) patients. Although this rate is comparable to that of some other CF pathogens, including Burkholderia spp., there was a potential bias in the sample set in that care centres are more likely to refer 'atypical' isolates for which the species identification may be in question. The presence of other, more common, CF-related pathogens, including Achromobacter, Burkholderia, Pseudomonas and Stenotrophomonas, was detected in only 13 (30%) of the 43 patients. This raises the possibility that the recovery of Bordetella may be influenced by the presence of other species that might ordinarily overgrow Bordetella in culture. If this is the case, N ⁄ A, method not specified; NLFGNR, non-lactose-fermenting Gram-negative rod. the prevalence of Bordetella within the CF population may well be underestimated. However, a prospective study of a non-biased sample set would be necessary to reach firm conclusions in this respect.
The role that these species may play in the progression of CF pulmonary disease is also unclear. Bordetella-infected patients ranged in age from 3 to 53 years, with 25 (58%) being aged <18 years. Only a single Bordetella isolate was identified among sputum culture isolates obtained serially for 41 of the 43 patients, suggesting transient colonisation with Bordetella. However, chronic infection is possible, with serial cultures from two patients yielding the same Bordetella strain for periods of 2 years (B. petrii) and 5 years (unidentified Bordetella sp.), respectively. No data were available concerning antimicrobial therapy given to these two patients during these periods.
The analysis revealed a high rate of misidentification of Bordetella spp. according to commercially available microbial identification systems, with 75% of the isolates (from 11 centres) being misidentified by the referring laboratory ( Table 1) . Misidentification of Bordetella as Achromobacter was particularly common, perhaps because of the incomplete and changing taxonomy of these two phylogenetically closely related genera. Indeed, a PCR assay designed to be specific for A. xylosoxidans on the basis of then available 16S rDNA sequence data [3] was positive for several isolates that were identified subsequently as Bordetella spp. It is noteworthy that cluster analysis of 16S rDNA sequences of the eight isolates identified as 'unclassified Bordetella' suggested the presence of at least four distinct, potentially novel, Bordetella spp. (data not shown).
In summary, this report describes the largest set of CF patients from whom Bordetella spp. have been identified, including the probable first report of B. avium infection in this patient population. Most isolates were identified incorrectly in initial testing by the referring laboratories, suggesting that further consideration should be given to the possible presence of Bordetella spp. in the evaluation of CF sputum culture.
A C K N O W L E D G E M E N T S
This work was supported by the Cystic Fibrosis Foundation (USA). The authors declare that they have no conflicting interests in relation to this work.
